Microbot Medical reported over 100% growth in revenue and new customers for Q2 2026, announcing plans to expand its U.S. sales territories and enter international markets. The period also saw significant M&A activity, with BiomX signing a letter of intent to acquire an Israeli security infrastructure firm, and Stereotaxis completing its acquisition of robotic innovator Robocath. Additionally, IKS Health finalized its acquisition of TruBridge, a provider of EHR and revenue cycle management solutions.
Medical technology firms bolster portfolios in surgical robotics and revenue management through the completion of key acquisition deals.
Read the full storyBiomX aims to bolster its security platform by acquiring a systems integration firm with two decades of experience in fire detection and building control.
The company achieved a surge in revenue and customer base driven by the LIBERTY robotic system launch, with international expansion plans set for year-end.